The global wart remover market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Warts are skin infections caused by human papillomavirus (HPV). Wart remover is a medication used to treat common skin or plantar warts. The rise in the prevalence of warts is anticipated to drive the growth of the global wart remover market. For instance, according to the data published by National Center for Biotechnology Information (NCBI) in 2021, approximately 10.0% of the population are affected by warts globally. Similarly, in school-aged children, the prevalence is accounted for 10.0% to 20.0%. Thus, as per NCBI, the occurrence of warts are more common among immunosuppressed patients and meat handlers. Moreover , warts can occur at any age, however, the prevalence is expected to increase among school-aged children and peak at 12-16 years. Thus, the rise in the prevalence of warts is anticipated to drive the demand for the global wart remover market.
Looking toward the demand for wart remover, key market players are adopting various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2021, Verrica Pharmaceuticals Inc had received approval from USFDA for its resubmitted New Drug Application (NDA) for VP-102. VP-102 is used to treat molluscum contagiosum and was assigned a prescription drug-free user act (PDUFA) goal date of May 2022. In addition, Verrica had completed a phase -2 study of VP-102 for the treatment of common warts and a phase -2 study of VP-102 for the treatment of external genital warts. Similarly, Verrica is also developing VP-103, a cantharidin-based product candidate, for the treatment of plantar warts. Moreover , VP-102 is expected to be marketed in the US under the conditionally accepted brand name YCANTH.
Further, in March 2021, Verrica Pharmaceutical Inc had entered into a license agreement with Torii Pharmaceutical Co, Ltd. granting torii an exclusive license to develop and commercialize Verrica’s product candidate VP-102 for the treatment of common warts in Japan. Under the terms of the agreement, Torii will make an upfront capital of $11.5 million and up to an additional $58 million in aggregate payments on the achievement of specified developments and sale milestones. Thus, such product launches coupled with strategic partnerships are anticipated to drive the growth of the global wart remover market during the forecast period.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Wart Remover Market at: https://orionmarketreports.com/request-sample/?id=95481&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Treatment
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– GlaxoSmithKline Plc, Pfizer Inc, Merck & Co, and Novan Inc among others.
A full report Wart Remover Market of is available at: https://orionmarketreports.com/wart-remover-market/95481/
Global Wart Remover Market Report by Segment
By Type
- Common Warts
- Genital Warts
- Flat Warts
- Others
By Treatment
- Salicyclic Acid
- Cidofovir
- Bleomycin
- Imiquimod
- Cantharidin
- Others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
